Dr. Taylor, Fellow of the Year recognition
Congratulations to Robert Taylor, MD for receiving Fellow of the Year from the Malcom Randall VA Medical Center.
Congratulations to Robert Taylor, MD for receiving Fellow of the Year from the Malcom Randall VA Medical Center.
During Digestive Disease Week, Anglea Pham, MD, presents results of IBD study relating to the college students with IBD and their higher risk of poor transition to college life. Read more about the presentation and study findings by Dr. Pham here.
Congratulations to Tony Brar, MD, named Fellow of the Year from the Department of Medicine Housestaff. Dr. Brar is recognized for his outstanding teaching abilities, leadership and cooperation. …
Join us in congratulating David R. Nelson, M.D., in being appointed senior vice president for health affairs at UF and president of UF Health. Dr. Nelson, professor of medicine and assistant vice president for research at UF, has served as the interim for this role for almost a year. He…
Distinguished Service Award: Presented to Dr. Peter Draganov by Dr. Robert Hawes and Dr. Michael Wallace Photo credit: Florida Gastroenterologic Society Dr. Peter Draganov…
Dr. Christopher E. Forsmark, chief of the division of gastroenterology, hepatology and nutrition at the University of Florida, was awarded the prestigious Vay Liang & Frisca Go Lifetime Achievement Award at the 2016 Annual Meeting of the American Pancreatic Association, which was held in Boston…
Exocrine pancreatic insufficiency isn’t your ordinary GI condition, but it’s often mistaken for one.
Congratulations to Dr. Forsmark and his pancreas diseases team – the National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announced the designation of twenty-eight additional National Pancreas Foundation Centers for the treatment and care of patients with pancreatic cancer.
University of Florida Health has enrolled its first patient in a landmark clinical trial to study the effectiveness of three hepatitis C medications. The initial patient has begun a 12-week drug regimen and is one of 3,750 people who will be randomly assigned one of the medications…